Hipace Pharmaceutical Private Limited

Hipace Pharmaceutical Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
CIN U51397DL2020PTC369413 Incorporated 07 September 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹24.41 Lakh
▲ 99% YoY
Net loss · FY 2024
₹11,904
Net margin -0.5%
EBITDA · FY 2024
-₹7,374
EBITDA margin -0.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Hipace Pharmaceutical Private Limited

Data last updated:

Hipace Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2020PTC369413.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saudan Singh and Simpi Pal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F/F Rz L – 9/287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.

As per the financials filed for FY 2024, the company reported a revenue of ₹24.41 Lakh, a growth of 99% compared to the previous year. For the same year it recorded a net loss of ₹11,904 (net margin -0.5%) and EBITDA of -₹7,374 (EBITDA margin -0.3%).

Hipace Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0015069).

Company details

CIN U51397DL2020PTC369413
Registration Number 369413
Incorporation Date 07 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0015069

Recognitions & Rankings of Hipace Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-DL-03-0015069

Contact details

Hipace Pharmaceutical Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    F/F Rz L – 9/287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Hipace Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hipace Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Hipace Pharmaceutical Private Limited, buy the company report.

Financials of Hipace Pharmaceutical Private Limited

FY 2025 filings available

Hipace Pharmaceutical Private Limited reported revenue of ₹24.41 Lakh (up 99% YoY) for FY 2024.

Revenue · FY 2024
₹24.41 Lakh ▲ 99%
Net loss · FY 2024
₹11,904 margin -0.5%
EBITDA · FY 2024
-₹7,374 margin -0.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 99%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 22%

Revenue rose 99% in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7,374
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11,904
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-0.3%
Net Profit Margin-0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hipace Pharmaceutical Private Limited, buy the company report.

Board of directors of Hipace Pharmaceutical Private Limited

Hipace Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Saudan SinghDirector07 Sep 20206 Years 1 MonthsCurrent
Simpi PalDirector07 Sep 20206 Years 1 MonthsCurrent

Peer comparison

Hipace Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sanmak Pharmaceuticals Private Limited₹24.48 Lakh (FY 2019)Haridwar, Uttarakhand, India
Rohan Pigments P Ltd₹24.46 Lakh (FY 2025)-3.0%Dombivli, Maharashtra, India
Naipunyaaayurvedics Private Limited₹24.46 Lakh (FY 2024)44.0%Kollam, Kerala, India
Velanutrition Nutraceuticals Private Limited₹24.45 Lakh (FY 2025)5077.0%Udhampur, Jammu and Kashmir, India
Cure Mantra Herbs Private Limited₹24.42 Lakh (FY 2025)-7.0%New Delhi, Delhi, India
Hipace Pharmaceutical Private Limitedthis company₹24.41 Lakh (FY 2024)-₹11,904-0.5%99.0%Delhi, India
Amtrack Laboratories Pvt Ltd₹24.4 Lakh (FY 2025)12.0%Mumbai, Maharashtra, India
Clonz Biotech Private Limited₹24.39 Lakh (FY 2025)-67.0%Hyderabad, Telangana, India
Parosha Chemicals Private Limited₹24.38 Lakh (FY 2023)326.0%Vadodara, Gujarat, India
Garrix Pharma Private Limited₹24.35 Lakh (FY 2024)59.0%New Delhi, Delhi, India
Nikit Chem Retails Private Limited₹24.32 Lakh (FY 2024)131.0%Ludhiana, Punjab, India

To see the full peer comparison of Hipace Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hipace Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Hipace Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Hipace Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Saudan Singh was appointed as Director on 07 Sep 2020.

AGM
Hipace Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hipace Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Saudan Singh was appointed as Director.
Appointed
Simpi Pal was appointed as Director.
Incorporation
07 Sep 2020
Hipace Pharmaceutical Private Limited was registered on 07 Sep 2020 with Roc Delhi I & aged 6 years 1 month as per MCA records.

Frequently asked questions

Hipace Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 September 2020 (6+ years old) and is registered under CIN U51397DL2020PTC369413.

Hipace Pharmaceutical has 2 current directors:

The latest financial statements of Hipace Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Hipace Pharmaceutical is U51397DL2020PTC369413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hipace Pharmaceutical was incorporated on 07 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Hipace Pharmaceutical by revenue are Sanmak Pharmaceuticals Private Limited, Rohan Pigments P Ltd, Naipunyaaayurvedics Private Limited, Velanutrition Nutraceuticals Private Limited, Cure Mantra Herbs Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Saudan Singh was appointed as Director on 07 Sep 2020. Simpi Pal was appointed as Director on 07 Sep 2020.

Yes, Hipace Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0015069).

The registered office of Hipace Pharmaceutical is at FF Rz L – 9287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.

Hipace Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Hipace Pharmaceutical can be reached at its registered office: FF Rz L – 9287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.